Effectiveness of disease management program for hypertension: expert evaluation

Authors

  • Akbayan M Markabayeva Doctor of PhD , Associate Professor-Researcher of the Department of Family Medicine №2, NJSC “Astana Medical University”, Astana city, Beibitshilik str., 49а , Republic of Kazakhstan
  • Aiman S Kerimkulova Candidate of medical sciences, professor , head of the Department of Family Medicine №2, NJSC “Astana Medical University”, Astana city, Beibitshilik str., 49а, Republic of Kazakhstan
  • Ayagyoz T Umbetzhanova Doctor of PhD , Associate Professor-Researcher of the Department of General practice with the cource of evidence based medicine , NJSC “Astana Medical University”, Astana city, Beibitshilik str., 49а, Republic of Kazakhstan
  • Riza G Nurpeissova MD, Cand. Sci. (Medicine), Associate professor of the Department of Family Medicine №2, NJSC “Astana Medical University”, Astana city, Beibitshilik str., 49а , Republic of Kazakhstan
  • Dinara K Zhunussova Candidate of Sciences in Medicine, Associate Professor of the Department of General practice with a course of evidence-based medicine, Astana medical university, Astana city, Beibitshilik str., 49а, Kazakhstan
  • Aysha Zh Darybayeva Associate Professor of the Department of Internal Medicine with a course in Nephrology, Hematology, Allergology and Immunology, Astana medical university, Astana city, Beibitshilik str., 49а, Kazakhstan
  • Saule Zh Kubekova PhD, Associate Professor-Researcher, Department of Internal Diseases with Geriatrics Course, Astana Medical University, Astana, Beibitshilik St. 49a, Kazakhstan
  • Zhadyra E Muslimkhanova Student of 6th course, NJSC “Astana Medical University”, Astana city, Republic of Kazakhstan
  • Ainur Donayeva Department of Emergency Medical Care, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
  • Kuralay K Sharipova Doctor PhD of the Human Anatomy named after Aubakirov A.B., Astana Medical University, Astana city, Beibitshilik street, 49A, Kazakhstan
  • Ainur S Ospanova Assistant of department of pediatrics and medical Rehabilitation named after Tusupova D.M., Semey Medical University, Semey, Abay Street, 103, Kazakhstan

DOI:

https://doi.org/10.3329/bjms.v24i4.84691

Keywords:

hypertension; disease management program; blood pressure control; outpatient treatment, lipid profile

Abstract

Background Hypertension is a risk factor for cardiovascular disease and premature mortality worldwide. Effective management of this condition requires the integration of structured interventions, such as disease management programs, which have proven clinically significant in increasing treatment adherence and improving patient outcomes. Objective To evaluate the effectiveness of a disease management program in achieving target blood pressure in primary care. Materials and methods A retrospective random sampling method was used to include 200 medical cards (form 025/u) of patients with arterial hypertension registered for dispensary care in 4 city polyclinics of Astana, Kazakhstan, for 2023-2024. Patients were divided into two groups depending on whether they achieved the target BP level (<140/90 mmHg). Clinical and laboratory parameters, including age, lipid profile, glucose level, and systolic/diastolic BP, were analyzed. The completeness of the disease management program implementation was also assessed using a criterion scale. Results Of the total number of patients, 170 (85%) successfully achieved the target blood pressure level, and 30 (15%) did not. Individuals with uncontrolled arterial hypertension were characterized by a significantly higher mean age (71.17 ± 10.87 vs. 66.08 ± 10.14 years; p < 0.05) and elevated levels of low-density lipoprotein cholesterol (LDL-C) (4.86 ± 1.75 vs. 3.53 ± 1.32 mmol/L; p < 0.05). Mean systolic and diastolic BP were also significantly higher in this group (142.83 ± 12.98/87.00 ± 5.63 mmHg vs 133.34 ± 12.41/82.43 ± 6.80 mmHg; p < 0.05). Full compliance with the Disease Management Program was associated with good clinical outcomes, with the group that achieved target blood pressure levels and fully complied with the program scoring significantly higher on the program implementation scores (8.2 ± 0.7 vs 5.6 ± 1.1; p < 0.001). Conclusion Full implementation of the disease management program significantly improves lipid profile and BP control in the primary care. The study also demonstrated the importance of regular follow-up, patient monitoring, and lifestyle interventions as key components of effective hypertension management.

BJMS, Vol. 24 No. 04 October’25 Page : 1181-1188

Downloads

Download data is not yet available.
Abstract
2
PDF
0

Downloads

Published

2025-11-02

How to Cite

Markabayeva, A. M., Kerimkulova, A. S., Umbetzhanova, A. T., Nurpeissova, R. G., Zhunussova, D. K., Darybayeva, A. Z., … Ospanova, A. S. (2025). Effectiveness of disease management program for hypertension: expert evaluation. Bangladesh Journal of Medical Science, 24(4), 1181–1188. https://doi.org/10.3329/bjms.v24i4.84691

Issue

Section

Original Articles